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of patient selection is clearly evident when PTCA is at- 
tempted in the presence of intracoronary thrombus. In 
one series,’ dilatation was complicated by occlusion in 
73% of patients compared to only 8% when thrombus was 
absent; the latter was a result of dissection. 
We derived a simple risk factor score from reports of 
the American College of Cardiology and the American 
Heart Association Task Force and major university hos- 
pitals2v3 Our results confirm the validity of these guide- 
lines. (Possibly, the risk score should have been weighted, 
so that thrombus was allocated at least 2 points.) Risk 
factors were identified by retrospective analysis of very 
large numbers of cases with a low rate of complications. 
Allowing for the technical expertise and experience of 
these operators, one could also assume that these risk 
factors were absent in most patients who did well, and the 
clinical material was therefore selected. With awareness 
of these lesion-specific risk factors, we believe we can now 
refer patients who will have fewer complications. Indeed, 
careful selection of low risk patients could probably blunt 
the so-called learning curve for the new PTCA operator. 
The results of PTCA would be more meaningful if, in 
future studies, risk factors were clearly defined prospec- 
tively for each patient. Because we acted as referring 
physicians, our data may have relevance to the results of 
PTCA in the community. Although the results are less 
than satisfactory, they may be similar to those obtained 
outside major centers that choose to report their results. 
In summary, careful assessment of angiographic le- 
sion-specific risk factors can identify a group of patients 
at high risk for intimal dissection and coronary artery 
occlusion. Because of the excellent prognosis of patients 
with 1 -vessel disease treated medically,4 a high risk factor 
score may militate against PTCA and suggest further 
medical treatment or coronary artery bypass surgery. 
Addendum: Since submission of this manuscript, an 
additional 66 patients had 79 arteries dilated (66 one- and 
13 two-vessel) at institution C between May 1988 and 
May 1989. The primary success rate was 94%. Acute 
closure with nonfatal myocardial infarctions complicated 
4 cases (6%). The lesion risk factor score was 1.75 f 0.48 
for acute occlusion and 0.44 f 0.8 (p <O.OOl) for pri- 
mary success. These findings confirm the favorable effect 
of patient selection. 
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Restenosis After Excellent Angiographic Angioplasty Result for 
Chronic Total Coronary Artery Occlusion- 
Implications for Newer Percutaneous Revascularization Devices 
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and Eric J. Topol, MD 
T he incidence of restenosis after coronary angioplasty for treatment of chronic total coronary occlusion is 
unacceptably high.’ The pathophysiology of restenosis 
after coronary angioplasty may be conceptually divided 
into an exuberant myointimal proliferation,2 and a resid- 
ual partial obstruction that serves as a platform for ather- 
oma regrowth and may potentiate that process by aug- 
menting blood flow turbulence and platelet deposition. 
The techniques of atherectomy or laser ablation3 may 
lessen the likelihood of restenosis by minimizing the resid- 
ual stenosis, although currently each may require supple- 
mental balloon angioplasty to achieve this result. How- 
ever, the effect of these techniques on later myointimal 
proliferation in human beings is largely unknown. The 
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concept that intracoronary stenting4 may reduce resteno- 
sis is based largely on the supposition that, by forcing and 
maintaining the obstructive atheroma out of the normal 
arterial lumen, turbulence and hence platelet deposition 
would be reduced5 and a large amount of myointimal 
proliferation would be required to recreate an obstruction 
of physiologic consequence. 
To assess the likelihood of restenosis after an excel- 
lent angiographic result with routine coronary angio- 
plasty for chronic total occlusion, and thereby to provide 
inferential data on the likelihood that newer interven- 
tional techniques will decrease restenosis in this setting, 
we reviewed all patients with successful coronary angio- 
plasty (final diameter stenosis GO% by electronic cali- 
pers or a validated computer-edged detection system) 
for chronic total occlusion (>3 days’duration) and a@- 
ographic follow-up from Emory University Hospital, the 
San Francisco Heart Institute and the University of 
Michigan Hospital before December 31, 1986. There 
were 257 stenoses that met these criteria, representing 
53% of all chronic total occlusions successfully dilated 
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TABLE I Angiographic Documentation of Restenosis 
Within Within Within 
3 Months* 6 Months* 12 Months* 
Group 1 (n = 37) 
Chronic total occlusion, 
final stenosis 110% (%) 
Group 2 (n = 69) 
Chronic total ocdusion. 
final stenosis 1 l-20% (%) 
Group 3 (n = 151) 
Chronic total occlusion. 
final stenosis >20% (I) 
Group 4 (n = 56) 
Subtotal occlusion, 
final stenosis 0+9% (%) 
11 30 52 
14 39 59 
24 45 73t 
7 26 39* 
l By lifetable analysis: t p <O.COl goup 3 versus flooups 1 and 2 by log rank 
amlysii * p <O.Ol vs grwps 1 tlwm& 3 by log rank analysis. 
during this time period. Patient age was 54 f 10 years 
(mean f standard deviation), 79% were men, the dura- 
tion of occlusion was I1 f 13 weeks and the diameter 
stenosis after angioplasty was 24 f 12%. Duringfollow- 
up, 82% of patients received aspirin, 27% received dipy- 
ridamole and 63% received warfarin. Stenoses were pro- 
spectively divided by final diameter stenosis. Group 1 
comprised 37patients with final stenosis 0 to lo%, group 
2 included 69 patients with final stenosis I I to 20% and 
group 3 had 151 patients with jhal stenosis >20%. In 
addition, 56 stenoses with initial diameter stenosis 50 to 
95% provided a “control” to inferentially assess the ef- 
fect of incomplete angiographic follow-up in these pa- 
tients (group 4). Groups 1 through 3 did not differ 
(Pearson chi-square >0.05) with regard to duration of 
total occlusion or distribution of arteries dilated, factors 
known to influence the risk of restenosis in this setting.’ 
Restenosis (diameter stenosis 30% from multiple 
views) was angiographically documented as listed in Ta- 
ble I. Thus, although the exact rates of restenosis cannot 
be determined without 100% angiographic follow-up, 
these data suggest that, although final diameter stenosis 
is an important predictor of risk of restenosis after angio- 
plasty for chronic total occlusion, even chronic total oc- 
clusions with excellent angiographic results after a@+ 
plasty are at high risk for restenosis. These findings may 
have important implications regarding the likelihood of 
restenosis after successful recanalization by newer abla- 
tive techniques or intracoronary stenting in this setting. 
Pharmacologic, immunologic or mechanical methods of 
altering the neointimal blood interface and thereby pre 
venting myointimal hyperplasia may be required to 
markedly reduce the risk of restenosis after any mechani- 
cal intervention to treat chronic total coronary artery 
obstruction. 
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Assessment by Doppler Color Flow Mapping of Ventricular Septal 
Defect After Acute Myocardial infarction 
Gerald Maurer, MD, Lawrence S.C. Czer, MD. Prediman K. Shah, MD, 
and Aurelio Chaux, MD 
R upture of the ventricular septum is an uncommon but lie-threatening complication of acute myocardi- 
al infarction (AMI). It occurs in <l% of infarcts. The 
noninvasive evaluation of such defects by 2-dimensional 
echocardiography has been reported.* These defects, 
however, can be difficult to image, particularly after an- 
terior AMI,*13 when they are usually located in the apical 
region. Doppler color flow mapping allows visualization 
of the shunt flow abnormality and may thus aid in the 
preoperative assessment of such defects. Color flow map 
ping has been used intraoperatively to evaluate valve re 
pair4 and closure of congenital shunt lesions.5 It may also 
be a useful tool in assessing the adequacy of repair of 
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ventricular septal rupture after AMI, which continues to 
carry a high mortality rate despite refinement of surgical 
technique. We report the use of Doppler color flow map 
ping for the bedside assessment of ventricular septal de 
fects complicating AMI, and its intraoperative applica- 
tion to assess the effectiveness of surgical repair. 
We studied 6 consecutive patients who presented to 
our coronary care unit with clinical manifestations sug- 
gestive of acute ventricular septal rupture after anterior 
(n = 4) or inferior wall (n = 2) AMI. The relevant 
clinical features are listed in Table I. The diagnosis of 
ventricular septal rupture was confirmed in all patients 
by oximetry, as well as in 4 of the dpatients at the time of 
surgery. Two patients died before surgery and autopsies 
were not performed. 
Echocardiographic imaging was performed from the 
parasternal, apical and subcostal windows. In addition 
to the standard planes, intermediate views were obtained 
by angling the transducer to visualize the defect, as well 
as the shunt flow, optimally. 
